The lym Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the lym Hub cannot guarantee the accuracy of translated content. The lym and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Lymphoma & CLL Hub is an independent medical education platform, sponsored by Beigene, Johnson & Johnson and Roche, and supported through educational grants from Bristol Myers Squibb, Incyte, Lilly, and Pfizer. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View lym content recommended for you
Ulrich Jäger
Scientific Advisory Board Member
Professor Ulrich Jäger is a Professor of Hematology at Medizinische Universitsat Wien, Vienna, AT, and Head of the Clinical Department for Hematology and Hemostaseology at the Vienna General Hospital, Vienna, AT. Prof. Jäger obtained his university degree in General Internal Medicine at the University of Vienna, AT, with specialization in hematology/oncology.
His research areas of interest include lymphoproliferative diseases (leukemia and lymphoma), chronic lymphocytic leukemia, non-Hodgkin lymphoma, acute lymphocytic leukemia, antibody therapies, and autoimmune hemolytic anemias.
Positions of responsibility/awards:
- President of the European Hematology Association (EHA) between 2011−2013
- Member of the Austrian Society of Hematology and Medical Oncology and the Austrian Society of Internal Medicine
- Member of the American Society of Hematology
- Member of the European LeukemiaNet, EHA, and the German CLL study group
- Winner of the Wilhelm Türk Prize of the Austrian Society for Hematology and Oncology in 1993, 1998 (together with Prof. Dr K. Laczika), 2002 (together with Dr M. N. Welzel), and 2003 (together with Dr R. Marculescu)
- Winner of the Prize of the "Erste Österreichische Sparkasse" (together with Dr R. Marculescu) in 2002
- Winner of the Aventis Prize, 2003, 2004
- Winner of "Großer Zentraluropäischer Preis" of the Vienna City Fund for innovative interdisciplinary cancer research, 2012
- Reviewer in top medical journals: Section Editor of the Annals of Hematology and Editor-in-Chief of the Vienna Clinical Weekly
Filter by content: